发明名称 GLUCOCORTICOID RECEPTOR AGONIST COMPOSED OF 2,2,4-TRIMETHYL-6-PHENYL-1,2-DIHYDROQUINOLINE DERIVATIVE HAVING SUBSTITUTED OXY GROUP
摘要 <p>Disclosed is a glucocorticoid receptor agonist composed of a compound represented by formula (1) or a salt thereof, which is a 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having a substituted oxy group.  A novel pharmacological action of the agonist is also disclosed.  In the formula, R1 represents a group represented by formula (2a), (3a), (4a) or (5a); R2 represents -(CO)-R8, -(CO)O-R9 or the like; R2-O- is substituted at the 4-position or the 5-position of the benzene ring A; R3 represents a lower alkyl group; R4, R5, R6 or R7 represents a halogen atom, an optionally substituted lower alkyl group or the like; m, n, p or q represents 0, 1 or the like; and R8, R9 or the like represents an optionally substituted lower alkyl group, a lower alkenyl group or the like.</p>
申请公布号 WO2009139361(A1) 申请公布日期 2009.11.19
申请号 WO2009JP58801 申请日期 2009.05.12
申请人 SANTEN PHARMACEUTICAL CO., LTD.;KATO, MASATOMO;TAKAI, MIWA;MATSUYAMA, TAKAHIRO;KUROSE, TATSUJI;HAGIWARA, YUMI;MATSUDA, MAMORU;MORI, TOSHIYUKI;IMOTO, KENJI;DOTA, ATSUYOSHI 发明人 KATO, MASATOMO;TAKAI, MIWA;MATSUYAMA, TAKAHIRO;KUROSE, TATSUJI;HAGIWARA, YUMI;MATSUDA, MAMORU;MORI, TOSHIYUKI;IMOTO, KENJI;DOTA, ATSUYOSHI
分类号 C07D215/14;A61K31/47;A61K31/4709;A61K31/506;A61K31/5377;A61P1/02;A61P1/04;A61P1/16;A61P3/08;A61P5/14;A61P5/16;A61P5/38;A61P5/44;A61P7/00;A61P7/04;A61P7/06;A61P9/00;A61P11/00;A61P11/02;A61P11/06;A61P13/12;A61P15/00;A61P17/00;A61P17/02;A61P17/04;A61P17/06;A61P17/14;A61P21/00;A61P21/02;A61P21/04;A61P25/00;A61P25/02;A61P25/28;A61P27/02;A61P27/16;A61P29/00;A61P31/00;A61P31/04;A61P31/06;A61P31/22;A61P35/00;A61P35/02;A61P37/02;A61P37/08;A61P39/02;A61P43/00;C07D401/12;C07D405/12;C07D409/12;C07D409/14;C07D413/12;C07D417/12;C07D417/14 主分类号 C07D215/14
代理机构 代理人
主权项
地址